Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep granted US patent for IMP761 agonist LAG-3 antibody (ASX:IMM)

SYDNEY, AUSTRALIA – 20 June 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapiesfor cancer and autoimmune disea...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep - Change in substantial holding (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep - Becoming a substantial holder (ASX:IMM)

To view the notice, download the attached PDF.

Immutep - Cleansing Notice (ASX:IMM)

To view the notice, download the attached PDF.

Application for quotation of securities - IMM (ASX:IMM)

To view the application, download the attached PDF.

Immutep letter to ineligible shareholders (ASX:IMM)

To view the announcement, download the attached PDF.

Immutep retail entitlement offer booklet (ASX:IMM)

Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep) is pleased to announce that it has today despatched a copy of the retail offer booklet (and accompanying personalised entitlement and accept...read more

Immutep - Positive final data in 2nd line head and neck cancer at ASCO (ASX:IMM)

Efti plus pembrolizumab led to deep, durable responses, regardless of PD-L1 expression levels, and median Duration of Response not reached despite median follow up of 39 months ...read more

Immutep completes institutional pro-rata offer & placement (ASX:IMM)

Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep or the Company) is pleased to announce the successful completion of the institutional placement (Placement) and the institutional component (In...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the notice, download the attached PDF.

Immutep - Cleansing Notice (ASX:IMM)

To view the notice, download the attached PDF.

Proposed issue of securities - IMM (ASX:IMM)

To view the notice, download the attached PDF.

Immutep Capital Raising Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep - A$80 million fully underwritten equity raising (ASX:IMM)

Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep or Company) is pleased to announce that it has launched an equity raising (Offer) through a fully underwritten pro rata accelerated nonrenoun...read more

Viewing: 76 - 90 of 200 Previous | Next